Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risk Prediction of Dexmedetomidine-associated Hemodynamic Instability
NCT03285087Phase 3Suspended
- Sponsor
- Assiut University
- Start
- Jun 2021
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexmedetomidine in sedation, sponsored by Assiut University. Started Jun 2021; status: suspended.
02
Drugs
dexmedetomidine
03
Conditions
sedation
Beyond the preview
Go deeper on NCT03285087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03285087.